SCRI shared a post on LinkedIn:
“We are pleased to announce Krish Patel, MD has been appointed executive director of Hematologic Cancer Research, expanding his leadership role to provide scientific and strategic direction across SCRI’s hematologic cancer portfolio.
We’re also pleased to welcome Shaolin Paul MBA, FCMA, CGMA as chief financial officer, where she will provide enterprise‑wide financial leadership in support of SCRI’s mission, research priorities, and continued growth.
To which Krish Patel, Executive Director, Hematologic Cancer Research at the Sarah Cannon Research Institute, added:
“It’s a true privilege to serve in this expanded role and I am thrilled to work with SCRI‘s expert investigators, scientists, and leaders across the organization to continue to advance research in hematologic cancers!”
Other articles about SCRI on OncoDaily.